1. Home
  2. TMDE vs BCTX Comparison

TMDE vs BCTX Comparison

Compare TMDE & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$0.80

Market Cap

14.6M

Sector

Energy

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.50

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
BCTX
Founded
2016
2014
Country
Malaysia
Canada
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
17.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TMDE
BCTX
Price
$0.80
$4.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
6.3M
706.8K
Earning Date
09-29-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$607,422,733.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$4.75
52 Week High
$6.27
$98.20

Technical Indicators

Market Signals
Indicator
TMDE
BCTX
Relative Strength Index (RSI) N/A 37.27
Support Level N/A $6.88
Resistance Level N/A $12.10
Average True Range (ATR) 0.00 0.83
MACD 0.00 -0.14
Stochastic Oscillator 0.00 0.65

Price Performance

Historical Comparison
TMDE
BCTX

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: